Dear Prospective Industry Partner,

The originally planned October 2020 International Innate Lymphocyte Conference in San Francisco (ILC4) is now being offered as a Joint Meeting with Cytokines 2022 Hybrid: 10th Annual Meeting of the International Cytokine & Interferon Society at the Hilton Waikoloa Village on the Big Island of Hawaii, USA.  Conference space has been booked to accommodate from 600 – 1,000 participants on site as well as an additional 500+ online via the virtual meeting platform (LabRoots) from Tuesday 20 through Friday 23 September 2022. The Virtual Meeting content (which will include both in-person and virtual presentations, always with live discussions), will be available on-demand following the live streamed sessions for three weeks, with some sessions, such as Industry Sessions and Educational Sessions, available for 12 months following the live event.

Although registered attendees of one meeting may participate in sessions of the other and there will be a few combined sessions and social functions, the ILC4 program will focus on ILC’s and be just as diverse and comprehensive as the previous three meetings have been.

By sharing a high profile island location attractive to in-person visitors — as well as the hybrid/virtual meeting platform to have improved access for those who may still not be comfortable, or just do not wish to fly around the world to hear about the latest research, the partnership with the International Cytokine & Interferon Society (ICIS) is a natural one. We hope you will still plan on joining us in Hawaii in September, 2022!

To help your company make the best of your participation at the meeting, we have put together a set of partnership opportunities that you can download here below:

Welcome Reception on the Lagoon Lanai, adjacent to the Grand Ballroom Foyer
Final Night Networking Dinner Event on the Ocean View Terrace Lawn
Tabletop Exhibits in the spacious, light and airy Grand Ballroom Foyer
Ocean View Terrace Lawn final night networking event dinner will close the meetings

The theme of the 2022 meeting concerns ILCs in tissue homeostasis and disease. Immunology has moved into the tissue space, and this conference highlights this transition as the core function of tissue resident cells in sustaining homeostasis and function in organs of the body.

The aim of this international conference series is to provide an interactive platform for the exchange of new concepts, ideas and data between immunologists interested in ILCs and innate lymphocytes in health and disease.

Based on past biennial meetings (Paris, 2014; Berlin, 2016; Tokyo, 2018), we anticipate an attendance of about 350 participants for the ILC program. Based on the successes of those conferences, it remains clear that ILCs have established themselves as new and significant players in the field of immunology, contributing to tissue homeostasis as well as defense against pathogens and inflammatory diseases. In addition to ILC research, studies on NKT, MAIT, and γδ T cells continue to inform our understanding of the role of innate lymphocytes in whole-body homeostasis and in the pathophysiology of disease.

We are compiling a scientific program covering basic aspects of innate lymphocyte biology as well as their roles in tissue homeostasis, immune regulation and disease by combining talks by invited expert speakers and selected abstract submissions to be presented as oral or poster presentations. Ample time will be reserved for networking, including a welcome reception, poster sessions together with the the tabletop exhibits in an adjacent ballroom and a Final Night Networking event planned as a Grand Joint Dinner Event out on the Lawn at the Hilton Waikoloa Village. The sessions will include internationally known invited speakers as well as short talks chosen from submitted abstracts on the following topics:

  1. ILC Development and Trajectories
  2. ILC Tissue Niches
  3. ILC1s and NK cells
  4. ILC2s
  5. ILC3s
  6. Central and Peripheral Nervous System and ILCs
  7. ILCs and Metabolism
  8. ILCs and Cancer
  9. ILCs and Atopic Diseases
  10. ILCs and Inflammatory Diseases
  11. Human ILCs
  12. ILCs as Therapeutics

The meeting will bridge the gap between the scientists performing basic research across the scope of these recently described cells and those working to harness this knowledge to develop strategies for interventions that restore tissue homeostasis.

The meeting is now organized under the auspices of the International Cytokine & Interferon Society, a non-profit, 501(c)(3) organization. All contributions to ILC4 will be acknowledged on the ILC4 program, the website, to attendees. 



Richard Locksley, MD, Chair, University of California, Howard Hughes Medical Institute, San Francisco, USA

Ari Molofsky, MD, PhD, MD, PhD, Department of Laboratory Medicine, UCSF

Lewis Lanier, PhD, Chair, Department of Microbiology and Immunology, UCSF

Mark Ansel, PhD, Director, Biomedical Sciences Graduate Program
Associate Professor, Department of Microbiology and Immunology, UCSF

For more information, please contact Candice Gabay, MCI Suisse SA or

Joan Oefner, ICIS Managing Director